BMRN - BioMarin Pharmaceutical Stock Trading

BioMarin Pharmaceutical Inc.(NASDAQ: BMRN) stock trading description contact officers and directors.

About BioMarin Pharmaceutical Inc.

Not available

Stock Information

BioMarin Pharmaceutical Inc. Company Name:

BMRN Stock Symbol:

NASDAQ Market:

Get BMRN Alerts

News, Short Squeeze, Breakout and More Instantly...

BMRN - BioMarin's Gene Therapy for Adults with Severe Hemophilia A, ROCTAVIAN(TM) (valoctocogene roxaparvovec), Assessed to Provide Substantial Cost Savings Per Patient in a Preliminary Independent Report

BioMarin's Gene Therapy for Adults with Severe Hemophilia A, ROCTAVIAN™ (valoctocogene roxaparvovec), Assessed to Provide Substantial Cost Savings Per Patient in a Preliminary Independent Report PR Newswire Institute for Clinical and Economic Review (ICER) Base-Ca...
BMRN - BioMarin- Progress in Treating Hemophilia

BioMarin (BMRN) has received European approval for its gene therapy for Hemophilia A, explains John McCamant, biotech sector expert and editor of The Medical Technology Stock Letter. For further details see: BioMarin- Progress in Treating Hemophilia
BMRN - First Gene Therapy for Adults with Severe Hemophilia A, BioMarin's ROCTAVIAN(TM) (valoctocogene roxaparvovec), Approved by European Commission (EC)

First Gene Therapy for Adults with Severe Hemophilia A, BioMarin's ROCTAVIAN™ (valoctocogene roxaparvovec), Approved by European Commission (EC) PR Newswire Maintains Orphan Drug Designation (ODD) in the EU Providing 10-years of Market Exclusivity Signif...